Status: Recruiting
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?
Participants needed: 30
Trial details
Phase: Early Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Arcato Laboratories, Inc.Updated: Mar 11, 2025Locations: 1
Eligibility criteria
Able to provide informed consent [+3]
Serious medical condition [+2]